WAVE LIFE SCIENCES LTD. Other Non-Current Assets
WAVE LIFE SCIENCES LTD. (WVE) had Other Non-Current Assets of $667.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-07-30
- 2026-06-30: Other Assets, Noncurrent $667.00K.
- 2026-03-31: Other Assets, Noncurrent $386.00K.
- 2025-12-31: Other Assets, Noncurrent $16.00K.
- 2025-09-30: Other Assets, Noncurrent $22.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $667.00K 10-Q · filed 2026-07-30 |
| 2026-03-31 | $386.00K 10-Q · filed 2026-04-28 |
| 2025-12-31 | $16.00K 10-Q · filed 2026-07-30 |
| 2025-09-30 | $22.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $728.00K 10-Q · filed 2025-07-30 |
| 2025-03-31 | $448.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $55.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $156.00K 10-K · filed 2025-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |